In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis to be a Agenda III drug. This rescheduling will recognize that cannabis has genuine clinical reasons and should help open up the doorway to research on other opportunity therapy employs. Ailments OF USE AND Essential https://hotbookmarkings.com/story20037503/little-known-facts-about-disposable-thc-vapes-uk